Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without

Gennaro Giustino1, Lisandro D Colantonio2, Todd M Brown3

  • 1Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Insights

Patients with diabetes mellitus (DM) face higher cardiovascular disease (CVD) risks post-acute myocardial infarction (AMI). Most patients on low/moderate-intensity statins after AMI do not switch to high-intensity statins, regardless of DM status, leaving residual CVD risk.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Patients with diabetes mellitus (DM) have an elevated risk of cardiovascular disease (CVD) events, particularly after an acute myocardial infarction (AMI).
  • High-intensity statin therapy is proven to reduce CVD risk in patients post-AMI, including those with DM.

Purpose of the Study:

  • To determine the proportion of Medicare beneficiaries aged 66-75 who transitioned to high-intensity statins after an AMI hospitalization.
  • To compare statin titration rates between patients with and without DM.

Main Methods:

  • Retrospective analysis of Medicare beneficiaries (66-75 years) hospitalized for AMI between 2014-2015.
  • Examined statin prescription fills within 365 days prior to and 30 days after AMI hospitalization.
  • Compared titration to high-intensity statins (atorvastatin 40/80mg, rosuvastatin 20/40mg) between patients with and without DM.

Main Results:

  • Only 37.7% of patients with DM and 44.4% without DM initiated high-intensity statins post-AMI.
  • No significant difference in the risk ratio for titrating to high-intensity statins was observed between patients with and without DM (RR 1.01).
  • Among those initially on lower-intensity statins, a small percentage (7.5% with DM, 9.2% without DM) escalated to high-intensity statins within 182 days post-AMI.

Conclusions:

  • A majority of patients, irrespective of diabetes status, do not escalate to high-intensity statins after AMI when initially prescribed lower-intensity statins.
  • This failure to optimize statin therapy may leave a significant portion of patients, especially those with DM, at increased risk for recurrent CVD events.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Titration of a Polyprotic Acid02:08

Titration of a Polyprotic Acid

A polyprotic acid contains more than one ionizable hydrogen and undergoes a stepwise ionization process.  If the acid dissociation constants of the ionizable protons differ sufficiently from each other, then the titration curve for such polyprotic acid generates a distinct equivalence point for each of its ionizable hydrogens. Therefore, titration of a diprotic acid results in the formation of two equivalence points, whereas the titration of a triprotic acid results in the formation of three...
105.3K
Acid-Base Titration Curves02:23

Acid-Base Titration Curves

A titration curve is a plot of some solution property versus the amount of added titrant. For acid-base titrations, solution pH is a useful property to monitor because it varies predictably with the solution composition and, therefore, may be used to monitor the titration’s progress and detect its endpoint. Acid-base titration can be performed with a strong acid and a strong base, a strong acid and a weak base, or a strong base and a weak acid.
For a titration carried out for 25.00 mL of...
141.5K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.4K
Titration Calculations: Weak Acid - Strong Base03:55

Titration Calculations: Weak Acid - Strong Base

Calculating pH for Titration Solutions: Weak Acid/Strong Base
For the titration of 25.00 mL of 0.100 M CH3CO2H with 0.100 M NaOH, the reaction can be represented as:
49.3K